Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Goodwill & Intangibles (2021 - 2026)

Xeris Biopharma Holdings filings provide 5 years of Goodwill & Intangibles readings, the most recent being $110.9 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 8.9% to $110.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $110.9 million, a 8.9% decrease, with the full-year FY2025 number at $110.9 million, down 8.9% from a year prior.
  • Goodwill & Intangibles hit $110.9 million in Q4 2025 for Xeris Biopharma Holdings, down from $113.6 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $154.3 million in Q4 2021 to a low of $110.9 million in Q4 2025.
  • Median Goodwill & Intangibles over the past 5 years was $132.6 million (2023), compared with a mean of $132.6 million.
  • Biggest five-year swings in Goodwill & Intangibles: fell 7.03% in 2022 and later fell 8.9% in 2025.
  • Xeris Biopharma Holdings' Goodwill & Intangibles stood at $154.3 million in 2021, then fell by 7.03% to $143.5 million in 2022, then dropped by 7.56% to $132.6 million in 2023, then dropped by 8.18% to $121.8 million in 2024, then fell by 8.9% to $110.9 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $110.9 million (Q4 2025), $113.6 million (Q3 2025), and $116.4 million (Q2 2025) per Business Quant data.